Sunshine, Binghamton University to develop cancer drug
Adva-27a is a small molecule inhibitor of Topoisomerase II, an enzyme found in abundance in multi-drug resistant breast cancer as well as in other types of aggressive cancer.
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Filed in 2009, the patent will cover inecalcitol doses higher than one milligram (mg) per day until 2029. Currently-marketed vitamin D analogues for indications such as rickets, osteoporosis